United States · Biotechnology startup

onc.ai

Onc.AI is a software that specializes in clinical oncology, genomics, proteomics, and radiomics.

Funding reportedLast round: Series A

BiotechnologySan Carlos, United States

What company datasets say onc.ai raised

Funding, as reported

Reported in all$31Min dollars
Rounds2
Last roundSeries A
Last round dateJan 2023
Investors listed11
SEC Form D$6.0M sold, 1 filing, last Dec 2020

Founders and team

From onc.ai's own website and the SEC filings it signed: 2 founders, 4 on the team.

Akshay NanduriFounder, CEONamed on its 2020 Form D
Salmaan AhmedFounder & VP SoftwareNamed on its 2020 Form D
  • Lester BoehChief Operating Officer
  • Beatriz LourencoData Analyst
  • Ian GreenbergBoard Member
  • Jonathan FlemingBoard Chair

On 3 portfolio pages

Investors who name them

Each firm lists onc.ai on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Biotechnology in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put onc.ai in front of investors. Or tell us what we have wrong.